Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Bicara Therapeutics Inc. Common Stock
IPO Date: September 13, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $557.91M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.62 | 4.06%
Avg Daily Range (30 D): $0.36 | 3.52%
Avg Daily Range (90 D): $0.51 | 4.34%
Institutional Daily Volume
Avg Daily Volume: .49M
Avg Daily Volume (30 D): .42M
Avg Daily Volume (90 D): .64M
Trade Size
Avg Trade Size (Sh.): 81
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 85
Institutional Trades
Total Inst.Trades: 225
Avg Inst. Trade: $1.5M
Avg Inst. Trade (30 D): $1.39M
Avg Inst. Trade (90 D): $1.13M
Avg Inst. Trade Volume: .11M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.7M
Avg Closing Trade (30 D): $1.56M
Avg Closing Trade (90 D): $1.15M
Avg Closing Volume: 125.86K
   
News
Jun 1, 2025 @ 5:12 PM
Bicara Therapeutics Demonstrates Deep and Durable ...
Source: N/A
May 22, 2025 @ 9:00 PM
Bicara Therapeutics Announces Publication of an Ab...
Source: N/A
Apr 23, 2025 @ 2:00 PM
Bicara Therapeutics to Present Updated Data from O...
Source: N/A
Sep 16, 2024 @ 8:01 PM
Bicara Therapeutics Announces Closing of $362 Mill...
Source: Globe Newswire
Sep 16, 2024 @ 8:01 PM
Bicara Therapeutics Announces Closing of $362 Mill...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $14.21 $-.68 $7.22
Diluted EPS $14.21 $-.68 $7.22
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -92.33M $ -36.85M $ -20.96M
Operating Income / Loss $ -108.8M $ -41.79M $ -26.64M
Cost of Revenue $ $ $
Net Cash Flow $ 273.66M $ M $ -31.05M
PE Ratio 0.83